Correvio Pharma Corp. Interest Paid, Excluding Capitalized Interest, Operating Activities
Correvio Pharma Corp. reported Interest Paid, Excluding Capitalized Interest, Operating Activities of $3.93 million for the 12-month period ending 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaidNet · last filed 2020-04-30
| Period end | Interest Paid, Excluding Capitalized Interest, Operating Activities 12 month |
|---|---|
| 2019-12-31 | $3.93M 20-F · filed 2020-04-30 |
| 2018-12-31 | $3.78M 20-F · filed 2020-04-30 |
| 2017-12-31 | $3.48M 20-F · filed 2020-04-30 |
| 2016-12-31 | $2.33M 20-F · filed 2018-04-30 |
| 2015-12-31 | $1.83M 20-F · filed 2018-04-30 |